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ABSTRACT 
The general utility of the planarian Schmiditea mediterranea, an organism with remarkable 
regenerative capacity, was investigated as a convenient three-dimensional model to analyse 
the import of cell penetrating peptides (CPPs) and bioportides (bioactive CPPs) into complex 
tissues. The unpigmented planarian blastema, 3-days post head amputation, is a robust 
platform to assess the penetration of red-fluorescent CPPs into epithelial cells and deeper 
tissues. Three planarian proteins, Ovo, ZicA and Djeya, which collectively control head 
remodelling and eye regeneration following decapitation, are a convenient source of novel 
cationic CPP vectors. One example, Djeya1 (RKLAFRYRRIKELYNSYR), is a particularly 
efficient and seemingly inert CPP vector that could be further developed to assist the delivery 
of bioactive payloads across the plasma membrane of eukaryotic cells. Eye regeneration, 
following head amputation, was utilised in an effort to identify bioportides capable of 
influencing stem-cell dependent morphogenesis. These investigations identified the 
tetradecapeptide mastoparan (INLKALAALAKKIL) as a bioportide able to influence the 
gross morphology of head development. We conclude that, compared with cellular 
monolayers, the S. mediterranea system provides many advantages and will support the 
identification of bioportides able to selectively modify the biology of totipotent neoblasts 
and, presumably, other mammalian stem cell types. 
 
1 INTRODUCTION 
The plasma membrane of eukaryotic cells generally acts to limit the intracellular 
accumulation of polar macromolecules, so restricting the target-specific access and efficacy 
of putative therapeutic agents. As summarised elsewhere,
[1-3]
 cell penetrating peptides 
(CPPs), usually short (< 25 amino acids) polycationic sequences, have tremendous potential 
to deliver bioactive cargoes, including macromolecular therapeutics, as both covalent and 
non-covalent complexes. Bioactive CPPs, or bioportides,
[4,5]
 can directly modulate the 
activities of intracellular proteins often by a dominant-negative influence upon protein-
protein interactions.
[6] 
Moreover, it is obvious that, in order to achieve a selective influence 
upon cells and tissues in vivo, CPP vectors and bioportides might need to traverse the 
physical impediments of both cutaneous and mucous membranes and those cellular barriers 
that enclose body cavities and immunologically privileged organs including brain and testis. 
More recently, a variety of innovative CPP technologies have been developed that, 
individually and collectively, serve to negate some of the challenges posed by diverse 
physiological barriers.
[7-10]
 Nevertheless, and despite many recent advances, a simple, reliable 
and robust system to evaluate CPP and bioportide import into complex tissues would be a 
useful adjunct to more complex in vivo assays; this objective was the starting point for this 
study. 
 The triploblastic bilateral planarian Schmiditea mediterranea, a free living 
representative of the phylum Platyhelminthes, is a model organism employed for studies of 
developmental cell biology, regeneration, embryology and stem cell function.
[11-16] 
The study 
of such fundamental biological processes is further aided by a comprehensive S. 
mediterranea genomic database (SmedGD 2.0)
[17]  
which enables data mining of both the 
genome and transcriptome. As previously discussed by others,
[11-13] 
planaria offer many 
advantages as a model organism that include: i) the ability to fully regenerate complete 
animals only days after amputation, ii) ease of maintenance, and iii) the presence of large 
numbers of adult stem cells. Moreover, there are surprising similarities between planarian 
proteins and those expressed in higher vertebrates; examples include G protein-coupled 
receptors,
[18]
  numerous determinants of pluripotency
[19]
 and transcription factors encoded by 
ovo and mammalian orthologs.
[20] 
Many bioactive peptides, some of which are homologues of 
mammalian hormones and neuropetides, regulate planarian physiology, regeneration and 
development.
[21-23]
 The demonstrated influence of exogenously applied tachykinin analogues 
upon stem cell proliferation
[14]
 provides further compelling evidence that planarians utilise 
peptide signalling pathways analogous to those in higher organisms. Moreover, the same 
study confirmed that exogenously applied peptides were able to access receptors expressed 
on their target cells having passed through a protective mucous layer now recognised to be 
remarkably similar to human mucosal secretions.
[24] 
Thus, we undertook the investigations 
described herein partly to evaluate S. mediterranea as a model system to study CPP and 
bioportide import in the presence of both physical and metabolic barriers and so address some 
of the challenges of targeted drug delivery in vivo.
[10,25] 
 
 A related goal of this investigation was to determine some biochemical properties of 
mimetic peptides derived from cationic domains of planarian proteins. Many human proteins 
which bind RNA and DNA possess readily-identifiable poly-arginine sequences that are 
effective cationic CPPs.
[26] 
 These polycationic domains may confer a ubiquitous membrane 
translocating mechanism to supercharged proteins.
[26,27]





 derive from transcription factors that are required to traverse 
plasma membranes. Logically, the activities of transcription factors intimately regulate the 
remarkable regenerative processes in planaria. More specifically, a conserved network of 
nuclear proteins, better resolved in Drosophila, is essential for eye development in S. 
meditteranea and hints at a common ancestor for this process in metazoans.
[20,30-32]
 Thus, our 







, known to regulate anterior pole and eye regeneration in planaria. The 
Djeya protein contains an evolutionary conserved EYA domain that enables it to interact with 
other nuclear proteins to control eye morphogenesis.
[33]
 Both Ovo and ZicA proteins are 
transcription factors that contain 3 or 4 C2H2-type zinc finger (ZF) DNA-binding domains 
respectively. One objective was to study the cellular uptake of fluorescent planarian protein-
derived CPPs and compare these with conventional CPPs derived from human proteins. This 
approach enabled the identification of the most efficient CPPs as delivery vectors for studies 
with multicellular planaria. A second objective of this study was to develop a platform to 
select bioportides which influence eye regeneration. Uniquely, the extreme regenerative 
capability of planarians is a consequence of an abundant (~20-30%) population of neoblasts, 





 neoblasts are relatively small (typically 7-12 
μm), morphologically undifferentiated cells with a strongly basophilic cytoplasm. As the only 
planarian cell type capable of proliferation, neoblasts are a remarkable stem cell model. Thus, 
CPP technologies capable of selective delivery to neoblasts within a syncytial parenchymal 
cell mass would offer clear advantages for the in vivo targeting, genetic manipulation and 
reprogramming of stem cells perhaps mediated by the delivery of proteins or 
oligonucleotides.
[35,36] 
 Such advancements will also underpin the development of 
technologies to study and manipulate stem cell function through the generation of transgenic 







2 METHODS AND MATERIALS 
2.1 Planarian culture 
Specimens of S. mediterranea, hermaphroditic sexual strain, were a kind gift from Kerstin 
Bartscherer (Max Planck Institute for Molecular Medicine, Münster, Germany). Animals 
were maintained at 18-20°C in planarian artificial medium (PAM) containing NaCl (1.6 mM), 
MgSO
4
 (1 mM), MgCl
2 
 (0.1 mM), KCl (0.1 mM), NaHCO
3
 (1.2 mM) and CaCl 
2
 (1 mM) in 
ultrapure water with gentamycin (3 g/ml).
 
[38]
 For convenience, stock solutions were 
prepared at 100X (PAM w/o CaCl
2
) and 200X (CaCl
2







added separately so as to avoid precipitation out of solution. Animals were routinely fed, 
three times a week with finely minced  bovine liver and ethically-sourced Icelandic cod 
(Waitrose). Planaria whose size reached 4-6 mm in length were selected for experimentation 
and, whence appropriate,  starved 5 days prior to amputation. 
 
2.2 Microwave-enhanced peptide synthesis 
The syntheses of a majority of CPPs and bioportides used in this study have been described 
elsewhere as reported in Table 1. Mimetic peptides derived from three planarian peptides 
were manufactured using microwave-enhanced peptide chemistry on a CEM Liberty Blue 
instrument equipped with UV analyser to determine coupling efficiencies.
[39]
 De novo 
peptides  were synthesized (0.1 mmole scale) on Rink Amide 4-Methylbenzhydrylaamine 
(MBHA) cross-linked polystyrene resins (Novabiochem) to generate peptide amides. Routine 
amino acid coupling at 90
o
C/120 s in Dimethylformamide (DMF) employed N,N'-
Diisopropylcarbodiimide  (Sigma) as the condensation reagent with the additive Ethyl 2-
cyano-2-(hydroxyimino)acetate (Oxyma).
[40] 
 Special coupling cycles were employed for Arg, 
double coupling 75
o
C/300 s, and Cys/His, single coupling 50
o
C/600 s, to reduce δ-lactam 
formation of Arg and racemisation of Cys/His respectively. A standard deprotection cycle 
with 20% (v/v) Piperidine in DMF was 90
o
C/60 s monitored by determining the UV 
absorption at 301 nm of Dibenzofulvene-piperidine adducts.
[39] 
 
 Amino-terminal acylation of peptides with 6-Carboxytetramethylrhodamine 
(Novabiochem) produced fluorescent peptides for confocal microscopy and quantitative 
uptake studies. All de novo peptides described herein were purified to apparent homogeneity 





2.3 Blastema formation and eye morphogenesis following treatment with 
bioportides 
Transverse amputation of planaria at the post-auricle and pre-pharynx level (Figure 1) 
induced blastema leading to eye regeneration and head remodelling. Amputation was 
performed in a 150 mm diameter x 25mm depth culture dish (Corning) containing filter-
sterilized PAM and used an ethanol-sterilized scalpel to minimize contamination at the site of 
the wound. To ensure accuracy in selection of the amputation site, a jewellers’ magnifier was 
employed.  Following amputation, planaria were treated immediately with 25 M bioportides 
or the positive control U1026 (10 M and 25 M; Calbiochem) in PAM in 35 mm diameter x 
10 mm depth culture dishes (Corning) to a final volume of 4 ml and maintained at 18-20°C.  
A 0.25% (v/v) DMSO control was included owing to the final assay concentration of DMSO 
when using 25 M U1026.  Those planaria treated with peptides underwent further treatments 
at 24 hours and 4 days post amputation to allow for temporal variation in both gene 
expression and protein signalling.
[31,41,42 ] 
Additionally, multiple treatments with bioportides 
circumvented any potential premature proteolysis of exogenously applied peptides. Treated 
planaria were allowed to regenerate for 7 days post amputation, whilst observations were 
performed daily to assess any morphological variations. Thereafter, planaria were transferred 
to a 24-well plate (1 planaria per well) in which they were immobilized, depleted of mucous 
and euthanised with N-acetylcysteine (5% w/v) in phosphate-buffered saline (PBS) at room 
temperature. Prolonged periods of treatment with N-acetylcysteine were avoided so as to 
avoid tissue damage. Immobilized planaria were transferred to fresh PBS and viewed with a 
Nikon Eclipse TS100 microscope equipped with a Nikon Digital-Sight camera. Images were 
captured using x4, x10 or x20 objectives (Figure 1). 
   
  
2.4 Intracellular accumulation of TAMRA-labelled CPP and bioportides in 
cells of the blastema: Preparations for confocal microscopy. 
Transverse amputations of planaria were performed as described above and beheaded 
specimens were maintained in PAM for 3 days at 18-20°C to allow for blastema formation 
(Figure 1). Thereafter, planaria were transferred to a 24-well plate (1 planarian per well) and 
treated with 1M or 5 M TAMRA-labelled CPP or bioportide to a final volume of 1 
ml/well for 1 hr. Following 6 washes with PAM, planaria were processed with N-
acetylcysteine (5% w/v) in phosphate-buffered saline (PBS) at room temperature for 5 
minutes, fixed with 10% neutral buffered formalin solution containing 4% (w/v) 
formaldehyde (Sigma) for 15-20 minutes at room temperature, then washed twice in PBS. 
Specimens were gradually dehydrated; treatment with 50% (v/v) ethanol in PBS for 5-10 
minutes at room temperature was replaced with 100% ethanol for 5-10 minutes. Specimens 
were transferred to -20
o
C for long term storage of up to 6 months. Fixation methods are 
adapted from those described by Pearson and co-workers
[43] 
who also suggest that methanol 
may be substituted for ethanol. However, despite the former reported to give a superior 
signal, it is only recommended for short-term storage at -20
o
C. For initial experiments using 
whole planaria instead of the unpigmented blastema, specimens were removed from storage 
at -20
o
C and placed in 6% H2O2 (30% stock Sigma) in ethanol and left overnight at room 
temperature. Thereafter, bleached specimens were returned to -20
o
C in 100% ethanol.
[43]
  
 Prior to confocal microscopic analyses, specimens were rehydrated with 50% (v/v) 
ethanol in PBS for 5 minutes at room temperature. Specimens were allowed to sink before 
replacement of 50% ethanol with PBS.
[43]
 PBS was then replaced with 80% (v/v) glycerol in 
PBS and samples were transferred to slides and mounted under Zeiss high precision glass 
coverslips (18mm x 18 mm, thickness 170 + 5 m). Specimens may be stored at 4
o
C in 80% 
(v/v) glycerol for 24 hours. Confocal analyses were performed using a Zeiss LSM 880 
Microscope. 
 
2.5 Quantitative uptake analysis 
Many of our previous studies
[39,44]
 have employed the U373MG astrocytoma cell line as a 
robust model to quantify the degree of cellular internalization of CPPs and bioportides. 
U373MG were maintained in a humidified atmosphere of 5% CO2 at 37
o
C in DMEM 
supplemented with L-glutamine (0.1 mg/ml), 10% (wt/vol) fetal bovine serum (FBS), 
penicillin (100 U/ml) and streptomycin (100 μg/ml). Following transfer to 6-well plates, cells 
were grown to 80% confluence, washed in phenol red-free DMEM and subsequently treated 
with TAMRA-conjugated peptides at a final concentration of 5 M for 1 hour in phenol red-
free DMEM. Cells were washed four times, detached with 300 l of 10 % (w/v) trypsin 
(without phenol red) at 37 °C, collected by centrifugation and lysed in 300 l 0.1 M NaOH 
for two hours on ice. Alternatively, samples may be stored at -20°C at this stage, defrosted 
and assayed at a later date. 250 l of each sample cell lysate were transferred to a black 96-
well plate, and analysed using a ThermoFischer Scientific Fluoroskan Ascent FL 
flurorescence spectrophotometer (λAbs 544nm/λEm 590 nm). 
 
3. RESULTS 
3.1 CPP and bioportide accumulation within planarian tissue 
To assess the propensity of CPPs and bioportides to penetrate planarian tissues, initial 
experiments were carried out using whole planaria, a methodology which required bleaching 
or tissue clearing of the whole organism (Section 2.4). However, of all CPPs tested during 






only the bioportide nosangiotide
[5]
 gave  a reliable and robust signal (Figure 2a).  
After injury, planarian neoblasts proliferate and migrate to the site of injury to form a 
mass of undifferentiated cells which later give rise to missing tissue.
[48] 
This unpigmented 
tissue mass, termed the blastema (Figure 1), provided us with a more convenient and robust 
model to explore the destination of TAMRA-labelled CPPs and bioportides using confocal 
microscopy, since the bleaching step was unnecessary and the signal to noise ratio was much 
improved (Figure 2). As highlighted in Figure 2, both the bioportide nosangiotide and the 
inert CPP vector C105Y, 
[49]
 demonstrated a predominant accumulation in the outer 
epithelium layer of the 3 day old blastemal (Figure 2c, d and e). Figure 2b depicts the cellular 
populations of the planarian blastema, the outer epithelium, neoblast-derived mesenchymal 
cells and neoblasts. Early epithelialization following injury is derived from migration and 
shape modifications of pre-existing epidermal cells,
[50] 
though the wound epidermis is 
continually supplemented by precursor cells from the newly formed neoblast-derived 
blastema.
[51] 
Figure 2e highlights elongation of wound epidermal cells, which has been 
attributed to partial wound relaxation following initial contraction.
[51]
 Below the epithelium 
Figure 2b additionally depicts neoblast-derived mesenchymal cells which will eventually 
differentiate into lost body parts
[50]
 and proliferating neoblasts, which during anterior head 
regeneration remain proximal to the blastema at the wound boundary.
[52]
 Confocal analyses 
taken at a lower optical Z plane along the blastemic dorsal-ventral axis (Figure 3a) 
established that both nosangiotide and C105Y had moved beyond the initial epidermal layer 
(Figure 2 f and g).  Accordingly, Figure 3b shows the bioportide mastoparan (MP) at 
different Z planes through the dorsal-ventral axis of the blastema. TAMRA-MP reaches 
approximately 30 m into the blastema (approximate depth of the blastema along the dorsal-
ventral axis 200m) from surface epithelial cells, though fluorescence intensity is reduced 
towards the lower limits of the Z axis. 
 
3.2 Design and synthesis of planarian-derived mimetic peptides 
The primary sequences of the planarian proteins Ovo (UniProtKB - 
J7FM12 (J7FM12_SCHMD)), ZicA (UniProtKB - X5CWX3 (X5CWX3_SCHMD)) and 
Djeya (UniProtKB - Q86FY6 (Q86FY6_DUGJA)) were extracted from the UniProt 
Knowledgebase (UniprotKB; https://www.uniprot.org/). C105Y
[49[
 (Table 1) is a somewhat  
atypical though highly efficient CPP with a Z value of just 1.9 whilst Tat
[28]
, Z = 9.0, is a 
more “typical” highly  polycationic sequence. Thus, in this study we sought to identify or 
design potential bioportides that were similar in length (16 AA) and net charge, 4 < Z < 9, to 
the anti-angiogenic peptide nosangiotide.
[5]  
Moreover, we restricted our search to 
rhegnylogically-organised bioportides,
[4-6]
 sequences in which the putative pharmacophores 
for both cellular penetration (address) and biological activity (message) are discontinuously 
organised within a single sequence. 
 In the case of Ovo and ZicA, the search for Arg- and Lys-rich sequences was 





designed as a mimetic of the first ZF domain of Ovo, extended at the N-terminal with the 
dipeptide Arg-Lys based upon sequence homology with the third ZF domain to add 







) combines cationic elements from all three ZF domains in a tandem construct 






 is a mimetic of the third 
ZF domain of ZicA with Leu substituted for a problematic Asp at position-8 and Arg 
replacing His at position-14. These changes, based upon homology with other ZF domains 
from ZicA, were made to reduce the potential for aspartamide formation during synthesis and 
increase cationic charge density at the C-terminal. ZicA2 (ZicA
220-235
) is a mimetic of the first 
ZF domain of the ZicA protein. Djeya1 (Djeya
391-418
), a slightly longer octadecapeptide, 
derives from a much larger conserved EYA domain of the Djeya protein from Dugesia 
japonica (Table 1). The EYA domain is believed to regulate gene transcription by 




3.3 Quantitative uptake analyses of planarian-derived mimetic peptides. 
We routinely utilize the U373MG astrocytic tumour cell line to quantitatively evaluate the 
penetrative propensities of CPPs and candidate bioportides.
[ 39,44]  
Thus, and as a comparative 
single cellular model, we determined the degree of cellular internalization of our rationally-
designed planarian-derived mimetic peptides. Most notably, Djeya1 gave the greatest 
translocation efficacy of 3.80 + 0.09 (data expressed as mean fluorescence minus background 
+ S.E.M and normalized so that Tat = 1), even exceeding the established CPP C105Y (3.47 + 
0.08) and Tat (1.00 + 0.03), (Figure 4). Translocation efficacies of the planarian-derived 
mimetic peptides were, in descending order, Chimeric-Ovo (0.76 + 0.08), Ovo1 (0.70 + 0.02), 
ZicA1 (0.68 + 0.04) and ZicA2 (0.34 + 0.02). As we have observed on numerous occasions 
within our laboratory, the bioportide nosangiotide preferentially accumulates within cells of 
endothelial origin. Accordingly, nosangiotide gave the lowest translocation efficacy of 0.06 + 
0.007, (Figure 4).   
 A major determinant of the biological activity of MP is its ability to incorporate into 
biological membranes as an amphipathic α-helix and present a region of cationic charge 
provided by Lysyl residues at positions 4,11 and 12. These cationic side-chains, together with 
the amino terminus, mimic the G-protein binding domain of G protein-coupled receptors 
(GPCRs).
[53]
 Consequently, MP is widely known as a receptor-independent activator of 
heterotrimeric G proteins. Moreover, when analysed using confocal live cell imaging,
[46]
 
rather than accumulating within the intracellular milieu, MP largely remains incorporated into 
the outer plasma membrane, thus in this assay system, MP demonstrates a penetrative 
propensity of 2.5 + 0.19.    
 
3.4 Qualitative confocal uptake analyses of planarian-derived mimetic 
peptides  
 
TAMRA-labelled planarian-derived mimetic peptides, designed to target anterior pole and 
eye regeneration, were incubated with living planaria 3 days post amputation. As with 
nosangiotide, C105Y and MP, all TAMRA-labelled peptides accumulated within the 
epithelium of the anterior pole of the blastemal (Figure 5). Of particular interest is the 
observation that TAMRA-Djeya was additionally located in cellular populations at a lower 
optical plane along the dorsal-ventral axis and proximal to the wound boundary (Figure 5). 
Of further significance is the observation that all CPPs and bioportides in this study were able 
to cross the biophysical mucous barrier secreted by planaria. To establish this finding, we 
purposefully treated whole planaria and 3 day-old amputees with TAMRA-labelled peptides 
prior to the removal of mucous with N-acetylcysteine (Section 2.4). 
3.5 Evaluation of planarian anterior pole regeneration and eye 
development following treatment with candidate bioportides. 
Immediately following amputation, animals were treated with 25 M planarian-derived 
mimetic peptides and monitored for morphological changes over a 7 day period, a strategy 
which allowed sufficient time for eye regeneration (Figure 6). As previously detailed in 
Section 2.3, additional treatments at the same concentration were included to allow for 
temporal variations in both gene expression and protein signalling of the parent planarian 
protein from which the candidate bioportides were derived, whilst also compensating for 
premature proteolysis of the peptide constructs. Inhibition of extracellular signal-regulated 
kinase (ERK) activity was used as a positive control to perturb blastema cellular 
differentiation and eye regeneration.
[54]
 More specifically, Tasaki and co-workers report
[54]
 
that ERK signalling is required for mitotic neoblasts to exit their proliferative state and 
undergo differentiation, whilst ERK inhibition resulted in severe defects in anterior pole 
regeneration such as a no eye phenotype and cyclopia. Thus, in accordance with previous 
reports, treatment of amputees with the MEK1/2 inhibitor U0126 impacted upon anterior pole 
regeneration (Figure 6). However, rather than observing serious eye defects, we observed an 
incomplete formation of the blastema at day 7 (Figure 6b). We have previously reported that 
MP and charge-delocalised analogues activate ERK 1/2 phosphorylation in U373MG 
astrocytic tumour cells.
[55] 
We were therefore curious to assess the effects of this bioportide 
upon regenerating planaria. In ~50% of cases, treatment of amputees with 25 M MP resulted 
in partial anencephaly, though eye regeneration was still evident (Figure 6g). 
Disappointingly, anterior pole and eye regeneration in those amputees treated with 25 M 
planarian-derived mimetic peptides, was identical to the untreated control (Figure 6a,d,e,f,h 
and i) and full regeneration of the eyespots including photoreceptors and the pigment cup 



























Data presented herein support the application of S. meditteranea, and almost certainly other 
planarian species, as a model organism(s) to study the import of CPPs and the discovery of 
bioportides capable of influencing fundamental physiological process such as regeneration 
and stem cell biology. Indeed, there are many additional lines of investigation which support 
this bold contention. In 2011 Gentile and co-authors
[13]
 listed a total of 29 planarian genes 
homologous to those encoding human proteins involved in diseases and there must surely be 
many more examples awaiting discovery in the S. mediterranea genomic database.
[17]
 It is 
also well established
[19]
 that there is a remarkable evolutionary conservation of pluripotency 
determinants in both planarian and mammalian stem cells. Specific examples of planarian 
homologues of human proteins studied in detail include Smed-p53,
[56]
 a protein which 
regulates self-renewal in neoblasts; Smed-TOR,
[57] 
a ubiquitously expressed Target of 
Rapamycin homologue which maintains a balance between cell division and cell death; and 
homologues of netrin and the netrin receptor,
[38] 
Smed-netrin, Smed-netR respectively, 
required for central nervous system regeneration. In the case of peptides, a variety of 
planarian hormones, neuropeptides and associated GPCRs are reported to be active in 
physiological process that include both cell proliferation and germline development.
[14,18,21,22]
  
 An overwhelming majority of studies employing and/or developing CPPs as delivery 
vectors have utilised monolayers of cultured cells.
[1-5] 
Hence, the S. mediterranea model 
described herein provides scope to address some of the more challenging obstacles, both 
pharmacokinetic and pharmacodynamic in origin, associated with intracellular delivery in 
vivo. Morphological assessment of macerated tissues identified a total of 13 basic cell types 
in planaria,
[58] 
compared with >200 in the human body. Considering also the relatively small 
size of S. mediterranea (≥ 6 mm), we propose that this organism is best considered a model 
of a single organ system. Thus, to reach intracellular sites, CPPs and bioportides must cross 
an epidermal/epithelial cell monolayer which is ciliated on the ventral surface. Our data 
indicate that these epithelial cells are efficiently penetrated by both CPPs and bioportides in 
S. mediterranea and it is noteworthy that epithelial cells surrounding organs also exhibit 
similar and common gross morphologies, positioning of intracellular organelles and 
localisation of membrane-bound receptors.
[59] 
We suggest that the S. mediterranea model also 
provides scope to further address the dynamic role of the epithelium in wound healing and to 
identify tools to explore the vital process of epithelialization. 
 Whilst CPP/bioportide import can be visualized in whole animals, the unpigmented 
blastema of S. mediterranea offers many advantages for microscopic studies. Fluorescent 
CPPs and bioportides are commonly utilized both to evaluate the kinetics and mechanisms of 
cellular import and to determine the distribution of peptides within complex tissues and 
various intracellular compartments.
[5,47] 
 We also sought to develop a method that could be 
employed with a more routine confocal microscopic system. We accept that there are 
limitations to this system, particularly with regard to the penetration depth which can be 
achieved with laser microscopy, and we anticipate that the method could be modified to 
include more elaborate approaches such as two-photon microscopy. Such advances should 
also enable the positive detection of RNA-rich basophilic neoblasts, a cell population that 
might reasonably be expected to readily accumulate cationic peptides. N-terminal acylation 
of peptides on a solid phase support is also a very common and convenient approach to the 
generation of fluorescent analogues which also negates any potential biochemical changes 
that might be directly related to the choice of fluorophore conjugation site.
[59] 
Our selection of 
the red-fluorescent tetramethylrhodamine (TAMRA) chromophore, added by activation of  a 
single isomer 6-Carboxytetramethylrhodamine, was dictated by several considerations: i) 
autofluorescence of planarian cells is problematic at wavelengths required to excite 
fluorescein conjugates; ii) TAMRA can enhance the cell-permeability of some CPP 
conjugates, compared to fluorescein
[60]
 but is membrane impermeable in a freely soluble 
form;
[61] 
iii) the fluorescent spectrum of TAMRA is relatively resistant to photo-bleaching 
during confocal analyses and mostly unaffected by other forms of interference such as 
cellular autofluorescence and intracellular degradation.
[61] 
Thus, the robust fluorescent signal 
that derives from TAMRA has been widely utilised to map the intracellular distribution of 
CPPs and biopoprtides, often in concert with organelle-specific fluorescent probes which 





conditions using sodium hydroxide were employed to quantify the intracellular uptake of 
TAMRA-labelled peptides into the U373MG cell line. Moreover, it is noteworthy that many 
alternative dyes such as fluorescein are pH-sensitive and as such require detergent-based lysis 
buffers such as those evaluated by Illien and co-workers 
[62]
 who recommend lysis conditions 
of 1M NaCl and 1% NP40 with sonication.  
 With the exception of MP, see below, none of the CPPs/bioportides compared in this 
investigation adversely influenced either the survival or regeneration of S. mediterranea. 
Thus, the relative simplicity of CPP technologies appear to be advantageous for the trans-







Those CPP, including Djeya1, which accumulated 
deeper along the dorsal ventral axis of the blastema show promise in targeting cellular masses 
other than the outer epithelial layer. Utilization of CPP technologies using the blastema as a 
tissue model could also provide the opportunity to target differentiating post-mitotic neoblast 
progeny,
[65] 
in addition to epithelial precursor cells or neoblast-derived mesenchymal cells. 
Future experiments will require specific markers and co-localization analyses to explore the 
destination of CPPs in planaria and further establish the blastema as a convenient in vivo 
complex tissue model. 
 As we anticipated from the results of similar studies,
[5,26,46]
 planarian proteins contain 
many cryptic polycationic sequences that are effective CPPs within a broad dynamic range. 
We could have employed a QSAR prediction algorithm
[5,44,66]
 in an effort to more accurately 
define these sequences. However, in this study we deliberately adopted Futaki’s approach
[26]
 
of selecting sequences rich in Arg (and Lys) that, in the case of Ovo- and ZicA-derived CPPs, 
mimic DNA-binding ZF domains. One of these novel mimetic sequences, Djeya1, is a 
particularly efficient CPP worthy of further investigation as a broad purpose intracellular 
delivery vector. A second rationale for selecting CPPs from ZF domains, and the conserved 
EYA domain of Djeya, was to facilitate the identification of bioportides that could modulate 
eye regeneration following functional loss. Decapitation of planarians is a very convenient 
strategy to generate a relatively transparent blastema suitable for confocal analyses. However, 
other techniques can be utilized to enable the surgical removal of a single eye,
[67,68]
 but it is 
noteworthy that the temporal regulation of planarian eye development remains constant 
despite variations in injury parameters or the need to simultaneously regenerate a functional 
brain.
[67] 
Employing the methodology described herein, we identified MP as a bioportide that 
influences head morphology. Whilst MP could induce necrosis/apoptosis of planarian cells, 
particularly at higher concentrations (> 10 µM), this observed action could also be a 
consequence of the activation of heterotrimeric G proteins
,[53]
 or regulation of signalling 
pathways mediated by ERKs.
[54,55]
 Further studies are necessary to clarify this intriguing 
observation, but we are confident that the S. meditterranea model will enable the 
identification bioportides capable of targeting and modulating the biology of  planarian 
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All sequences are peptide amides, a modification that impacts upon the calculation of Z 
values which range from 1.9 -9.0. Planarian-derived peptides are reported here for the first 
time and were synthesized using the CEM Liberty Blue system. All peptides were purified to 
apparent homogeneity and their identity confirmed by mass spectrometry using Bruker 
MALDI TOF or Agilent QTOF instruments. Unless otherwise indicated, microwave-
enhanced amino acid couplings utilised the routine parameters described in the methods 
section. Mass data and z values reported refer to peptides with a free N-terminal. Ovo1, 
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FIGURE 1  Amputation, blastema formation, anterior pole and eye regeneration in the S. 
mediterranea model. A schematic representation of novel methodologies employed to: (i) 
evaluate CPP import into the complex tissues of the blastema; (ii) assess the impact of 
planaria-derived candidate bioportides and other bioactive agents on anterior pole 
remodelling and eye regeneration. Upper panels show the location of the amputation site and 




FIGURE 2  CPP accumulation within blastema cells: Convenience of using the blastema 
compared to whole planaria. a) Living planaria were treated with TAMRA-nosangiotide (10 
M) for 1 hr prior to removal of mucous, fixation and bleaching. b) Cellular populations of 
the planarian blastema as adapted from Newmark & Alvarado (2001).
[50] 
Signal to noise ratio 
was improved by utilizing 3 day old blastemic tissue in addition to lowering the application 
concentration of TAMRA-labelled CPP from 10 M to 1 M (c,d,e,f,g). TAMRA-
nosangiotide (c) and TAMRA-C105Y (d,e) accumulate within surface epithelial cells of the 
blastema following 1 hr incubation. TAMRA-nosangiotide (f) and TAMRA-C105Y (g) also 
accumulate at a lower Z plane along the dorsal-ventral axis. Epithelial cells still visible at 
these lower optical planes are denoted by “e”.  For all blastema images, the anterior pole is to 
the left.  Images are representative of 3 independent experiments. Scale bars (c, 20 m), (d, 






FIGURE 3  Accumulation of TAMRA-MP through the dorsal-ventral axis. Panel (a) shows 
the anatomical axes of the planaria. Confocal images are of the blastema only and the anterior 
aspect is to the left. b (i, ii, iii, iv and iv) show TAMRA-MP (5 M) following 1 hr incubation 
accumulating within cells of the blastema at descending points along dorsal-ventral axis and 
the corresponding Z planes at which the images were captured are indicated to the right. 
Panels b (iv) and b (v) depict images captured at a lower magnification. 3 day old blastemas 
were treated with TAMRA-labelled peptides prior to removal of mucous and fixation. Images 
are representative of 3 independent experiments. 
 
FIGURE 4  Comparative analysis of peptide translocation efficacies into the U373MG cell 
line model. U373MG cells were incubated with TAMRA-labelled peptides (5 M) for 1 h at 
37
o
C.  Data are expressed as mean fluorescence minus background + S.E.M and normalized 
so that the mean value for Tat is equal to 1.0, n = 3. 
 
FIGURE 5  Qualitative uptake analyses in vivo. 3 day old blastemas were treated with 5 M 
TAMRA-labelled planarian-derived peptides ai) Djeya1, b) Chimeric-Ovo, c) Ovo1, d) 
ZicA1, e) ZicA2, for 1 hr prior to removal of mucous, fixation and confocal examination. 
Images are also presented here with differential interference contrast (DIC) so as to highlight 
the unpigmented tissue of the blastema and are representative of 3 independent experiments. 
aii) depicts Djeya1 also accumulating at a lower Z plane along the dorsal-ventral axis, 
treatment was identical to (aii). The dorsal view is presented for all peptides except ZicA1 (d) 
which shows the ventral view including the pharynx. 
 
FIGURE 6  Eye regeneration assay. Decapitated planaria were treated with 25 M planarian-
derived peptides d) Djeya1, e) Ovo1, f) Chimeric-Ovo, g) MP, h) ZicA1, i) ZicA2 and 
blastema were allowed to regenerate. On day 7 (images shown), planaria were immobilized, 
euthanized and transferred into PBS for light microscopic analysis. Images were acquired 
with x4, x10 and x20 objectives as indicated and are representative of 6 independent 
experiments. U0126 (25 M and 10 M were used as positive controls for the assay and 
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